CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10

This publication has 16 references indexed in Scilit:

• Effect of the CYP2D6*10 genotype on venlafaxine pharmacokinetics in healthy adult volunteers
  British Journal of Clinical Pharmacology, 1999
• Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population
  Pharmacogenetics, 1998
• Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects
  Pharmacogenetics, 1995
• Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population*
  Clinical Pharmacology & Therapeutics, 1995
• Genetic basis for differences in debrisoquin polymorphism between a spanish and other white populations
  Clinical Pharmacology & Therapeutics, 1994
• Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
  Proceedings of the National Academy of Sciences, 1993
• Genetic polymorphism of cytochrome P450 CYP2D6 in Zimbabwean population
  Pharmacogenetics, 1993
• The role of individual human cytochrpmes P450 in drug metabolism and clinical response
  Trends in Pharmacological Sciences, 1992
• Debrisoquine/Sparteine Hydroxylation Genotype and Phenotype: Analysis of Common Mutations and Alleles ofCYP2D6in a European Population
  DNA and Cell Biology, 1991
• Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification
  The Lancet, 1990